Cytospire Therapeutics Ltd
- Biotech or pharma, therapeutic R&D
Cytospire is developing an innovative portfolio of differentiated multispecific engager antibodies to enhance and direct the activity of gamma delta T cells to treat cancer and autoimmune disease.